Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy
Clinical trial NCT06501651 · UNKNOWN
Trial details
- NCT number
- NCT06501651
- Sponsor
- Sichuan Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-04-10
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.